Efficacy of the Hsp90 Inhibitors in Prostate Cancer Therapy

Journal Title: Journal of Urology & Nephrology - Year 2014, Vol 1, Issue 1

Abstract

Prostate cancer is a disease of aging and the second leading cause of death in men in the United States. A distinctive characteristic of prostate tumors is their dependence on androgen for development, growth and survival. The molecular chaperone Heat Shock Protein-90 (Hsp90) is involved in the stability of a number of protein targets including androgen receptor (AR). Preclinical data demonstrates Hsp90 inhibition to be an effective therapy for inhibiting prostate cancer cells in culture as well as in animal xenograft models. Two newgeneration Hsp90 inhibitors, ganetespib and AT13387, are currently being evaluated as single or combinational therapies in the clinic for castrate resistant prostate cancer (CRPC). While clinical signs of antitumor activity have been observed with new-generation HSP90 inhibitors, these drugs are likely to be most effective when used as part of combination treatments. This review highlights how inhibition of Hsp90 combined with specific secondary targets including Wee1, Hsp27, ERK and mTOR displays enhanced inhibitory effects in pre-clinical models. One clinical benefit of co-inhibition is the targeting of multiple signaling pathways. In addition, the variety of proposed combination therapies allows for latitude in selecting a secondary target, potentially tailoring therapies to specific patient populations.

Authors and Affiliations

Mehdi Mollapour

Keywords

Related Articles

Testicular Epidermoid Cyst: Case Report and Literature Review

Introduction: Testicular epidermoid cysts are extremely uncommon. They are considered as benign tumors. Although an inguinal orchiectomy is the standard procedure for testicular tumors, if the presence of an epidermoid c...

Lower Urinary Tract Dysfunction after Radical Hysterectomy for Cervical Cancer

Despite effective screening, cervical cancer continues to be a major public health problem among women. Radical hysterectomy represents the cornerstone in the management of localized cervical cancer especially in young w...

Pelvic and Abdominal Lipomatosis – A Rare Case Report with Atypical Presentations

Pelvic lipomatosis is defined as a condition characterized by the diffuse proliferation of normal mature fatty tissue in the perirectal and perivesical region. We present a rare case of 50 years male, normotensive, normo...

Cocaine Intoxication: A Rare Cause of Thrombotic Microangiopathy

Cocaine abuse and intoxication is a global problem leading to many medical complications that can result in significant morbidity and mortality. Many lesions, including thrombotic microangiopathy, can cause acute renal i...

Bacterial Ecology of Peritonitis in a Sub-Saharan Peritoneal Dialysis Unit

Introduction: Peritonitis is a common and serious complication of Peritoneal Dialysis (PD). Peritonitis is a major cause of PD technique failure and conversion to long-term hemodialysis. After acquiring 10 years of exper...

Download PDF file
  • EP ID EP207434
  • DOI 10.13188/2380-0585
  • Views 151
  • Downloads 0

How To Cite

Mehdi Mollapour (2014). Efficacy of the Hsp90 Inhibitors in Prostate Cancer Therapy. Journal of Urology & Nephrology, 1(1), 1-9. https://europub.co.uk/articles/-A-207434